tbuckley/cabot-search huggingface dataset:
The Reason Why We Should Differentiate Monomorphic Epitheliotropic T Cell Lymphoma and Intestinal T Cell Lymphoma, NOS - a Retrospective Study about the Experience of a Single Tertiary Hospital in Korea
Authors: Jiyeon Hyeon, Changgon Kim, Sang Eun Yoon, Seok Jin Kim, Young Hyeh Ko, Junhun Cho, Won Seog Kim
Journal: Blood (2024)
Chronic Myelomonocytic Leukemia 10 Years of Single Institute Experience
Authors: Samah Ahmed Samy Kohla, Abdulrahman Al-Mashdali, Hawra Shawayli, Sarah Elkourashy, Dina Sameh Soliman, Kalpana Singh, Susanna Akiki, Mohammed Yasin, Feryal Abbas, Shehab Mohamed
Journal: Blood (2024)
In Vitro and In Vivo Potency Differences between AAVRh74var and AAV5 Vectors Encoding the Same High-Activity Human Factor IX Variant, FIX-R338L, Expression Cassette: Implications for Hemophilia B Gene Therapy
Authors: Debra D Pittman, Swapnil Rakhe, Lisa J Wilcox, Daniel LeBlanc, Vicente Pagan, Megan L Brophy, Diana Sapashnik, Annette Sievers
Journal: Blood (2024)
Nursing Management of Subcutaneous Daratumumab at Home: A Safe and Effective Procedure for Frail Patients with Multiple Myeloma
Authors: Elisa Emanueli Cippitelli, Vincenza Innocenti, Roberta Perazzini, Roberta Talucci, Alessia Fiorini, Giulio Trapè, Maria Gabriela Chavez, Roberta Agrippino, Michela Tarnani, Cristina Mastini, Alessandro Andriani, Marco Montanaro, Roberto Latagliata, Gioia De Angelis, Silvia Ciambella
Journal: Blood (2024)
Mortality Trends in Non-Hodgkin Lymphoma Patients with High Body Mass Index: A Comparative Study of the USA and Europe from the Global Burden of Disease Registry (1991-2021)
Authors: Charmi Bhanushali, Kalaivani Babu, Srinishant Rajarajan, Jayalekshmi Jayakumar, Sripada Preetham Kasire, Arya Mariam Roy
Journal: Blood (2024)
Study of Real-World Treatment Patterns in Patients with Sickle Cell Disease Using US Medicaid Claims Data
Authors: Xunming Sun, Yun Gu, Budhaditya Goswami, Jamie Ye, Carmine Colavecchia, David M. Purdie, Anan Zhou, Michelle A. Silver, Kui Huang, Stephen E. Schachterle
Journal: Blood (2024)
Letermovir for Prevention of Cytomegalovirus Infection in Chinese Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients: A Phase 3, Open-Label, Single-Arm Trial
Authors: Yun He, Lanping Xu, Yujun Dong, Xianmin Song, Yicheng Zhang, Erlie Jiang, Hu Yu, Ren Lin, Ying Wang, Xiaodan Guo, Weiwei Zhao, Cyrus Badshah
Journal: Blood (2024)
Polatuzumab Vedotin, Rituximab, Cyclophosphamide, Doxorubicin and Steroids (PolaRCHP) in Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): Real-Life Experience in Greece
Authors: Theodoros P. Vassilakopoulos, Maria Panagiota Arapaki, Christina Apostolopoulou, Georgia Kaiafa, Anastasia Mpanti, Chara Giatra, Evgenia Verrou, Maria Anastasia Ioakeim, Evangelia Fedra Triantafyllou, Michael-Evangelos Makris, Athanasios Anastasiadis, Alexia Piperidou, Athanasios Liaskas, Maria Delatola, Aikaterini Koutsi, Vasileios Xanthopoulos, Sotirios Sachanas, Eirini Katodrytou, Maria Bouzani, Marina Siakantaris, Panayiotis Panayiotidis, Maria Angelopoulou, Sotirios G. Papageorgiou
Journal: Blood (2024)
Outcome of Extra-Nodal Follicular Lymphoma Affected By Selection of Induction Chemoimmunotherapy and Maintenance Rituximab - Real-World Retrospective Study
Authors: Lawrence Cheng Kiat Ng, Shin Yeu Ong, Xinxin Huang, Aditi Ghosh, Chandramouli Nagarajan, Yeow Tee Goh, Yunxin Chen, Francesca Lim, Xiu Hue Lee, Jing Yuan Tan, Nicholas Francis Grigoroloupos, Joshua Tian Ming Hoe, Jianbang Chiang, Esther Chang, Eileen Poon, Ya Hwee Tan, Nagavalli Somasundaram, Valerie Shiwen Yang, Miriam TAO, Soon Thye Lim, Jason Yongsheng Chan
Journal: Blood (2024)
Promising Developments: Trends of Patient-Reported Outcomes in Diffuse Large B Cell Lymphoma Clinical Trials
Authors: Nitya Batra, Mahnoor Sukaina, Rahul Mishra, Madhan Srinivasan Kumar, Avi Harisingani, Sameer Deshmukh, Tulika Garg, Kamalpreet Singh Walia, Sadia Ansar, Suhana Preet Kaur, Atulya Aman Khosla, Karan Jatwani, Mohammad Muhsin Chisti, Muhammad Salman Faisal
Journal: Blood (2024)
Letermovir Primary Prophylaxis in Preventing Cytomegalovirus (CMV) Reactivation in <i>Ex-Vivo</i> Tcrαβ-Depleted Haploidentical Allogeneic Haematopoietic Cell Transplantation with Memory T Cell Add-Back
Authors: Ao Ran Boo, Yi Ching Yuen, Chin Menn Woon, Michelle Poon, Lip Kun Tan, Joanne Shu Xian Lee, Victor Ling, Yeh Ching Linn, Hein Than, Zi YI LIM, Colin Phipps Diong, Liang Piu Koh
Journal: Blood (2024)
Predictive Value of Liver Sitffness Measurement for Early Diagnosis of Veno-Occlusive Disease and Final Stem-Cell Outcomes
Authors: Manuel Jorge Fernández Villalobos, Rebeca Bailen, Ignacio Alberto Gomez Centurion Luna, Pablo Silva, Lucia Castilla Garcia, Paula Fernández-Caldas, Sonia Alonso, Adriana Ahumada, Carlos Iniesta, Rafael Bañares, Ramon Garcia-Sanz, Mi Kwon
Journal: Blood (2024)
A Retrospective Cohort Study to Assess and Compare Treatment Patterns and Healthcare Utilization for Patients with Mantle Cell Lymphoma in the Veterans Affairs System (MCLOVA) Who Were Prescribed Bruton Tyrosine Kinase Inhibitors (BTKi)
Authors: Henry Ogbeifun, Supreet Kaur, Zohra Nooruddin, Cynthia I Nguyen, Corbyn M Gilmore, Adriana M Vargus, Kathleen Franklin, Xavier Jones, Christopher Frei
Journal: Blood (2024)
Enhanced Validation of the <i>FLT3</i>-like Gene Expression Signature As a Predictive Biomarker for Quizartinib Response in <i>FLT3-ITD</i> Negative Acute Myeloid Leukemia: Expanded Cohort and Extended Follow-up from the Pethema Quiwi Trial
Authors: Adrian Mosquera Orgueira, Manuel Perez Encinas, Carlos Pérez Míguez, Rebeca Rodriguez Veiga, Juan Miguel Bergua Burgues, Jesus Lorenzo Algarra, Carmen Botella, Jose Antonio Perez Simon, Teresa Bernal, Mar Tormo, Maria Calbacho, Olga Salamero, Josefina Serrano, Victor Noriega, Juan Antonio Lopez Lopez, Susana Vives, Mercedes Colorado, Jose Luis Lopez Lorenzo, Maria Vidriales Vicente, Raimundo Garcia Boyero, Maria Teresa Olave Rubio, Pilar Herrera Puente, Olga Arce, Manuel Barrios Garcia, Maria Jose Sayas Lloris, Marta Polo, Maria Isabel Gomez Roncero, Eva Barragán, Rosa Ayala, Carmen Chillon, Maria Jose Calasanz, Blanca Boluda, Andres Peleteiro Raindo, Raquel Amigo, David Martinez-Cuadron, Jorge Labrador, Pau Montesinos
Journal: Blood (2024)
The Differential Effects of Bridging Therapy on Immune Microenvironment and Outcomes with Idecabtagene-Vicleucel in Multiple Myeloma
Authors: Praneeth Reddy Sudalagunta, David R. Noyes, Gabriel De Avila, Alexandra Achille, Rafael Renatino-Canevarolo, Xiaohong Zhao, Maria Silva, Angel Perez, Mark B. Meads, Lauren C. Peres, Doris K. Hansen, Kenneth H. Shain, Ariosto Siqueira Silva
Journal: Blood (2024)
Evaluation of Measurable Residual Disease Assessment Dynamics in Hairy Cell Leukemia Clinical Trials from 1980 to 2020
Authors: Oscar Borja Montes, Altamash Jawadi, Sushrruti Varatharaj, Hannah E Herring, Tomas Escobar Gil, Narendranath Epperla, Leslie A. Andritsos
Journal: Blood (2024)
Circulating Tumor DNA Predicts Venous Thromboembolism in Minority Patients with Cancers
Authors: Shengling Ma, Jun Yang Jiang, Rockbum Kim, Elizabeth Chiang, Joyce Tiong, Justine Ryu, Danielle Guffey, Raka Bandyo, Heidi Dowst, Kaitlin N Swinnerton, Nathanael R. Fillmore, Jennifer La, Ang Li
Journal: Blood (2024)
Impact of Graft Cell Dose on Outcomes after Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide-Based Gvhd Prophylaxis
Authors: Muhammad Umair Mushtaq, Amir Kasaeian, Sibgha Gull Chaudhary, Muhammad Kashif Amin, Iqra Anwar, Hediyeh Alemi, Naghmeh Khavandgar, Aleenah Mohsin, Matthew McGuirk, Sunil Abhyankar, Mehdi Hamadani, Joseph P. McGuirk, Moazzam Shahzad
Journal: Blood (2024)
Impact-AML: A European Project for Optimizing Treatment and Assessing Quality of Life in Relapsed/Refractory Acute Myeloid Leukemia Patients
Authors: Antonio Maturo, Elisa Castellaccio, Veronica Moretti, Samantha Nier, Giovanni Martinelli, Giovanni Marconi, Gerardo Musuraca, Simone Adelsbach, Martina Vittoria Minguzzi, Maria Belles Esteller
Journal: Blood (2024)
Understanding Causes of Disparate Outcomes in Pediatric Acute Leukemia: Social Vulnerability Index As a Predictor for Increased Hospitalizations for Infections during Intensive Chemotherapy
Authors: Nali Gillespie, Alexis Brantley, Morgan Viviano, Zhide Feng, Leah Smith, Maria C C. Velez-Yanguas, Zachary LeBlanc
Journal: Blood (2024)
Pre-Transplant Diabetes Is Associated with Increased Risk of Relapse after HCT: A Single Center Experience
Authors: Annalisa Paviglianiti, Marta Bellver Sanchis, Marta Peña, Inmaculada Peiro Martinez, Felipe Peña, Lidia Hurtado, Raquel Lopez Gil, Alberto Mussetti, Montserrat Arnan, Helena Pomares, Eva Gonzalez Barca, Patricia Lopez Pereira, Rocky Strollo, Paolo Pozzilli, Anna Sureda Balari
Journal: Blood (2024)
Improved Outcomes with Myeloablative Conditioning in AML Patients below 65 Years Using a Combination of Antithymocyte Globulin and Post-Transplantation Cyclophosphamide As Gvhd Prophylaxis
Authors: Ahmed Alnughmush, Ruah Alyamany, Mats Remberger, Ivan Pasic, Igor Novitzky-Basso, Arjun Law, Wilson Lam, Dennis Dong Hwan Kim, Fotios Michelis, Armin Gerbitz, Rajat Kumar, Jonas Mattsson, Auro Viswabandya
Journal: Blood (2024)
An Examination of Side-Effects in CAR-T Versus Other Therapies in Patients with Relapsed Lymphoma and Chronic Lymphocytic Leukemia - an Analysis from the Lymphoma Coalition's 2024 Global Patient Survey on Lymphomas &amp; CLL
Authors: Steve E Kalloger, Amanda Watson, Shawn Sajkowski, Kathryn Perry, Natacha Bolanos, Lorna Warwick
Journal: Blood (2024)
A Real-World Pharmacovigilance Analysis of Cardiac Adverse Events Associated with Newer Antibody-Drug Conjugates: A Disproportionality Analysis from FDA Adverse Event Reporting System Database
Authors: Deepika Dilip, Pritika Sharma, Arpita Pawa, Ben Wu, Kassidy Veasaw, Elizabeth Drugge, Amir Steinberg
Journal: Blood (2024)
A Retrospective Analysis of US Commercial and Medicare Closed-Claims Databases to Evaluate Real-World Characteristics and Treatment Patterns of Patients with Diffuse Large B-Cell Lymphoma (2017-2023)
Authors: Tycel Phillips, Ziqi Zhou, Cynthia Gutierrez, Anran Shao, Marley Boyd, Sina Noshad, Andriana Hohlbauch, Nicholas Liu, Karen Repetny, Michelle Fanale, Betsy Mitchell, John M. Burke
Journal: Blood (2024)
Identifying Risk Factors for Progression to Blastic Phase in Chronic Myeloid Leukemia Patients Under Imatinib Therapy: A Cohort Analysis
Authors: Lyam Carlo Chacon Rangel, Fausto Alfredo Rios-Olais, Mariem Pulido, Ivan Arnaud-Borboa, Fernando Solís-Huerta, Roberta Demichelis, Elena Juventina Tuna Aguilar
Journal: Blood (2024)
Differential Antiviral IgG Titer Decay Rates after Frontline Chemoimmunotherapy in Patients with Aggressive B Cell Lymphoma
Authors: Andres Chang, Alyssa Leal, Michael Churnetski, Lilin Lai, Susanne Linderman, Hasan Ahmed, Colin B O'Leary, Rustom Antia, Madhav V. Dhodapkar, Mehul Suthar, Jean L. Koff, Jonathon B Cohen, Rafi Ahmed
Journal: Blood (2024)
Feasibility of Discontinuation of Bruton's Tyrosine Kinase Inhibitors in Patients with Chronic Lymphocytic Leukemia: A Patient Survey
Authors: Deborah M. Stephens, Chris Stewart, Liza Avruch, Catherine C Coombs, Alexey Danilov, Brian T. Hill, Mazyar Shadman, Alina S. Gerrie, Christopher E. Jensen, Marc Hoffmann, Allison M. Winter, Daniel A. Ermann, Paul M Barr, Susan M. O'Brien, Brian Koffman, John C. Byrd
Journal: Blood (2024)
T-Cell Memory Compartment Downregulation and NK Cell Activation Are Associated with Myelofibrosis Progression
Authors: Mariana Medeiros, Camila Araújo Bernardino Garcia, Larissa Sarri Binelli, Allana Guimarães de Carvalho, Leticia Olops Marani, Priscila Santos Scheucher, Josiane Lillian Schiavinato, Leonardo Carvalho Palma, Pedro Manoel Marques Garibaldi, Robert Welner, Lorena Lobo Figueiredo-Pontes
Journal: Blood (2024)
Outcomes of Waldenström Macroglobulinemia Patients Requiring Therapeutic Plasma Exchange. Higher Rates of Progression and Resistance of Initial Systemic Therapy
Authors: Jessica Leng, Jack Khouri, Allison M. Winter, Deepa Jagadeesh, Robert M. Dean, Taylor R. Brooks, Louis Williams, Faiz Anwer, Craig S. Sauter, Brian T. Hill, Paolo F. Caimi
Journal: Blood (2024)
Real-Life Outcomes of Bosutinib in Patients with Chronic Myeloid Leukemia: A Multicenter Nationwide Study from Turkey
Authors: Serkan Guven, Deniz Özmen, Yunus Çatma, Tuba Güllü Koca, Onur Kırkızlar, Ömer Şeker, Sercan Ünal, Seçil Salim, Betül Kübra Tüzün, Aslı Yüksel Öztürkmen, Nergiz Erkut, Esra Kiriktir, Nesibe Taşer Kanat, Püsem Patır, Abdülkadir Karışmaz, Seval Akpınar, Emel Gürkan, Nurcan Özçelik Kürkçü, Öznur Aydın, Gülsüm Çağlıyan, Ayfer Gedük, Süleyman Arslan, Zehra Narlı Özdemir, Rafiye Çiftçiler, Ayşe Uysal, Merve Aydoğan, Yıldız İpek, Merve Ecem Erdoğan Yön, Zeynep Tuğba Karabulut, Emel Bostan, Sinan Mersin, Tarık Onur Tiryaki, Vildan Gürsoy, İrfan Yavaşoğlu, Ali Doğan, Güchan Alanoğlu, Mehmet Baysal, Eren Arslan Davulcu, Ayşe Kaya, İbrahim Ethem Pınar, Abdülkerim Yıldız, Gülşah Akyol, İnci Alacacıoğlu, Mutlu Arat, Mesut Ayer, Meltem Aylı, İlhami Berber, Ahmet Muzaffer Demir, İbrahim Haznedaroğlu, Fehmi Hindilerden, Erdal Kurtoğlu, Meliha Nalçacı, Fahir Özkalemkaş, Vildan Özkocaman, Güray Saydam, Mehmet Sönmez, Selami Koçak Toprak, Tülin Tuğlular, Burhan Turgut, Mehmet Turgut, Ahmet Emre Eskazan
Journal: Blood (2024)
Clinical Outcomes and Adverse Events Among Patients with Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma (CLL/SLL) Initiating First-Line (1L) Ibrutinib: Analysis of Subgroups Receiving Subsequent Second Generation (2G) Bruton Tyrosine Kinase Inhibitors, Non-Bruton Tyrosine Kinase Inhibitor Therapy, or Ibrutinib Retreatment in the US Community Oncology Setting
Authors: John M. Burke, Ira Zackon, Brittani Wayne, Yunfei Wang, John Murphy, Jennifer Prescott, Shravanthi Gandra, Siyang Leng, Enrico De Nigris
Journal: Blood (2024)
Prognostic Value of Baseline and Early Response FDG-PET/CT Combined with Cellular Dynamics in Patients with Refractory and Relapsed Mantle Cell Lymphoma (MCL) Undergoing Chimeric Antigen Receptor (CAR)-T Cell Therapy
Authors: Simon M Krauß, Sabine Seiffert, Carmen Perez Fernandez, Thomas Walter Georgi, Janine Kirchberg, Enrica Bach, Mandy Brueckner, Madlen Jentzsch, Carmen Herling, Maximilian Merz, Klaus H Metzeler, Marco Herling, Georg-Nikolaus Franke, Andreas Boldt, Solveig Tiepolt, Regine Kluge, Ulrike Koehl, Timm Denecke, Osama Sabri, Ulrich Sack, Uwe Platzbecker, Lars Kurch, Vladan Vucinic
Journal: Blood (2024)
Correlation between the Integrated MDS Flow Cytometry Score and Genomic Abnormalities - a Single Centre Analysis from King's College Hospital
Authors: Henry Wood, Lauren Jamieson, Charles Manogaran, Katy Jones, Kar Lok Kong, Josephine Goodwin, Steve Best, Azim Mohamedali, Aytug Kizilors, Nicholas C Lea, Zoe Thorn, Frances Aldridge, Liron Barnea Slonim, Prudence Hardefeldt, Guy Hannah, Shireen Kassam, Deborah Yallop, Austin G. Kulasekararaj
Journal: Blood (2024)
Effects and Molecular Mechanism of Inhibiting p53 Signaling Pathway By NSUN6 on the Resistance to BCL-2 Inhibitor for Diffuse Large B-Cell Lymphoma
Authors: Yuanfei Shi, Yanchun Zhao, Yi Xu, Jianai Sun, Xiaolong Zheng, De Zhou, Jie Jin, Hongyan Tong, Wanzhuo Xie
Journal: Blood (2024)
Rituximab +/- Ibrutinib As First Line Therapy for Marginal Zone Lymphoma
Authors: Ariela Noy, Win Su Thet, Shreya Vemuri, Venkatraman Seshan, Connie Lee Batlevi, Zachary D. Epstein-Peterson, Lorenzo Falchi, Paola Ghione, Thomas M. Habermann, Paul A. Hamlin, Erel Joffe, Jennifer Kimberly Lue, Matthew Matasar, Maria Lia Palomba, Andrew D. Zelenetz, Gilles Salles
Journal: Blood (2024)
PBCAR19B, an Immune Evading Allogeneic CAR T Stealth Cell, Demonstrates Potent Anti-Tumor Responses and Prolonged B Cell Depletion Supporting Sustained Immune Evasion in Patients with Relapsed/Refractory (R/R) B-Cell Lymphoma (NHL)
Authors: Usama Gergis, Aaron Martin, Alex Vogel, Jeff Smith, Andreas Klein, Ran Reshef, Rajneesh Nath, Adam J. Olszewski, Alan List, Alex F. Herrera, Michael D. Jain
Journal: Blood (2024)
A Phase Ib/II Study of Trovocabtagene Autoleucel (C-CAR088), an Anti-BCMA CAR T-Cell Therapy in Relapsed or Refractory Multiple Myeloma
Authors: Gang An, Yan Xu, Shuhua Yi, Rui Lyu, Jiaqi Huang, Wensi Li, Yiran Zhang, Liping Lan, Lugui Qiu
Journal: Blood (2024)
Efficacy and Safety of Zanubrutinib Monotherapy in Real-World Chinese CLL/SLL Patients
Authors: Shenmiao Yang, Huayuan Zhu, Ru Feng, Xutao Guo, Ting Niu, Jian-Qing Mi, Zhenling Li, Qianqian Ju, Liru Wang, Yujun Dong, Bingjie Wang, Liang Wang, Wanling Sun, Fang Fang, Liping Su, Yu Zhao, Xiaojun Huang, Jianyong Li
Journal: Blood (2024)
High <i>WEE1</i> Expression Correlates with Poor Survival in Multiple Myeloma, Independent of Standard Prognostic Factors
Authors: Anish Kumar Simhal, Ross S Firestone, Jung Hun Oh, Larry Norton, Malin Hultcrantz, Saad Z. Usmani, Kylee H Maclachlan, Joseph O. Deasy
Journal: Blood (2024)
Evaluation of the New Minion Chemistry and Duplex Basecalling for Immunoglobulin Gene Analysis in Chronic Lymphocytic Leukemia
Authors: Jordi Martinez-Serra, Julieta Nastasi, Blanca Ferrer Lores, Alicia Serrano-Alcalá, Adrian Moquera, Antonia Sampol Mayol, Maria Jose Terol Castera, Antonio Gutiérrez
Journal: Blood (2024)
Retrospective Single-Institution Review of Bosutinib Dose Optimization for Efficacy and Safety with Dose Ramp-up and Titration
Authors: Jessica Freydman, David Sirignano, Philip C. Amrein, Meghan Bergeron, Andrew M. Brunner, Elsie Foster, Amir T. Fathi, Timothy Aaron Graubert, Hanno Hock, Michelle Hyunju Lee, Jenna Moran, Rupa Narayan, Gabriela S. Hobbs
Journal: Blood (2024)
Real-Life Use of Asciminib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Results of the Turkish Managed Access Program
Authors: Deniz Özmen, Derya Deniz Kürekçi, Vildan Özkocaman, Burcu Altındağ Avcı, Denis Sabriye Bozer, Mutlu Kasar, Osman Şahin, Gülten Korkmaz Akat, Ferda Can, Mehmet Sezgin Pepeler, Nergiz Erkut, Onur Kırkızlar, Kübra Yel Uygun, Tuba Bulduk, Murat Yıldırım, Müzeyyen Aslaner Ak, Şermin Altındal, Fatma Arıkan, Mehmet Sinan Dal, Burak Deveci, Nil Güler, Ahmet Kürşad Güneş, Emel Gürkan, Demircan Özbalcı, Osman Can Öztürk, Burcu Ülküden, Hüseyin Yılmaz, Meltem Kurt Yüksel, Meltem Aylı, Ahmet Muzaffer Demir, Düzgün Özatlı, Fahir Özkalemkaş, Güray Saydam, Mehmet Sönmez, Burhan Turgut, Mehmet Turgut, Ali Ünal, Ahmet Emre Eskazan
Journal: Blood (2024)
Disease Course and Risk Model Validation of Asymptomatic Waldenström Macroglobulinemia Patients - a Single Center Experience
Authors: Theresia Akhlaghi, Jose Fernandez-Rengifo, Mateo Mejia Saldarriaga, Sarah C. Rutherford, Cara Rosenbaum, Jorge Monge, Peter Martin, John N. Allan, Richard R. Furman, Ruben Niesvizky, Mark Bustoros
Journal: Blood (2024)
Targeting Druggabble Long Non-Coding RNA MALAT1: Epigenetic Regulation of CD38 and Energy Metabolism in Multiple Myeloma
Authors: Shih-Feng Cho, Wen-Hsin Chang, Wei-Ting Liao, Tsung-Jang Yeh, Hui-Ching Wang, Jeng-Shiun Du, Chin-Mu Hsu, Hui-Hua Hsiao, YI-Chang Liu
Journal: Blood (2024)
Evaluating the Safety of Combining Tyrosine Kinase Inhibitors with Anticoagulants in Chronic Myeloid Leukemia : A Systematic Review
Authors: Amna Gameil, Rola Ghasoub, Neda Jafari, Laila Shafei, Maria Benkhadra, Saad Laws, Liam Fernyhough
Journal: Blood (2024)
Early Versus Standard Initiation of Immunosuppressive Therapy for Graft Versus Host Disease Prophylaxis in Haploidentical Allogeneic Stem Cell Transplantation: Incidence and Severity of Cytokine Release Syndrome and Related Outcomes
Authors: Luisa V. Carvalho, André Dias Americo, Camila Carminati Isoppo, Isabella Pittol, João A. G. G. Prats, Eurides L. Rosa, Germano Lima, Natalia Fumagalli, Paula Lucafo Zenero, Hegta R. Figueiroa, Fauze Lutfe Ayoub, Juliana Matos Pessoa, Jose Ulysses A. Filho, Fabio R. Kerbauy, Phillip Scheinberg
Journal: Blood (2024)
Dexamethasone and Daratumumab Impair T-Cell Mediated Killing in Multiple Myeloma: Implications for Sequential Therapies
Authors: Ilaria Dulcamare, Sara Marino, Nunziatina Laura Parrinello, Grazia Scandura, Enrico La Spina, Daniela Cambria, Grazia Scuderi, Cesarina Giallongo, Daniele Tibullo, Alessandra Romano, Francesco Di Raimondo
Journal: Blood (2024)
First Results of Asciminib As Initial Therapy with Addition of Lower Dose Tyrosine Kinase Inhibitors for Patients with Chronic Myeloid Leukemia Who Do Not Achieve a Deep Molecular Remission (ALERT CML) from the H Jean Khoury Cure CML Consortium (HJKC3)
Authors: Jorge E. Cortes, Michael J. Mauro, Alexis Visotcky, Srinivas K Tantravahi, James E Thompson, Jay Yang, Arielle Baim, Yan Gao, Sonia Maldonado-Schmidt, Claire Olig, Kathryn E. Flynn, Jerald P. Radich, Ehab L. Atallah
Journal: Blood (2024)
Validation and Implementation of Flow Cytometry Based Minimal Residual Disease (MRD) Assay for Chronic Lymphocytic Leukemia (CLL) Clinical Studies
Authors: Christele Gonneau, Marc Brugarolas, Lotje Van Haecht, Marc Lenjou, Caitlyn Fritsche, Yevgeniy Linnik, Lucas Rifkin, Ting Yu, Simon Rule, Veerendra Munugalavadla, Yoav Peretz
Journal: Blood (2024)
Cardiac Glycosides Induce Immunogenic Changes in Myeloma Cells and Enhance the Efficacy of Monoclonal and Bispecific Antibody Therapy
Authors: Tomoyuki Nakamura, Masaki Ri, Toru Ebina, Yoshiaki Marumo, Yoshiko Oshima, Hirokazu Sasaki, Arisa Asano, Shiori Kinoshita, Tomotaka Suzuki, Tomoko Narita, Takaomi Sanda, Hirokazu Komatsu, Yasumichi Inoue, Hidetoshi Hayashi, Shinsuke Iida
Journal: Blood (2024)
Chimeric Antigen T-Cell (CAR-T) Therapy Versus Autologous Stem Cell Transplantation (ASCT) in Secondary Central Nervous System Lymphoma (SCNSL): A Multicenter Retrospective Analysis
Authors: Joseph G Bennett, Kamen Kossow, Leah Diebolt, Nicole Twardowski, Jianzheng Wu, Dinesh Pal Mudaranthakam, Shaun DeJarnette, Brian Hess, James A Davis, Al-Ola Abdallah, Nausheen Ahmed, Joseph P. McGuirk, Marc Hoffmann
Journal: Blood (2024)
Cytopenias and Failure to Use Innovative Therapy Are Main Drivers of Worse Outcome after Discontinuation of Ruxolitinib in Myelofibrosis
Authors: Francesca Palandri, Massimo Breccia, Erika Morsia, Giulia Benevolo, Mario Tiribelli, Eloise Beggiato, Mirko Farina, Bruno Martino, Giovanni Caocci, Novella Pugliese, Alessia Tieghi, Monica Crugnola, Gianni Binotto, Francesco Cavazzini, Elisabetta Abruzzese, Alessandro Isidori, Alessandra Dedola, Emilia Scalzulli, Alessia Moioli, Veronica Guglielmana, Santino Caserta, Andrea Duminuco, Roberto Massimo Lemoli, Daniela Cilloni, Monica Bocchia, Fabrizio Pane, Florian Heidel, Elena Maria Elli, Massimiliano Bonifacio, Giuseppe Alberto Palumbo, Filippo Branzanti
Journal: Blood (2024)
Establishment of CD19-CAR-T Cell Production and Treatment of Non-Hodgkin Lymphoma in the United Arab Emirates
Authors: Mohamed I. Abu Haleeqa, Inas El-Najjar, Yara K Afifi, Sheima A Ali, Nameer Alsaadawi, Jayakumar David Dennison, Mansi Sachdev, Sakher A Obeidat, Yandy Marx Castillo Aleman, Rupert Handgretinger, Asia Ibrahim, Rasha Wahdan, Fatema al Kaabi, Yendry Ventura-Carmenate, Loubna A Hadi, Antonio Hernández-Ramírez, Maysoon Al Karam
Journal: Blood (2024)
A Retrospective Analysis of Efficacy and Safety of Orelabrutinib Maintenance in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma
Authors: Zhiming Li, Jun Fang, Huilai Zhang, Wei Wang, Hui Li, Hui Zhou, Liqun Zou, Hong Cen, Wen Shujuan, Wuping Li, Peng Sun, Panpan LIU, Hang Yang, Yu Wang
Journal: Blood (2024)
Auto-HSCT Vs CAR-T Cell Therapy for Paients with Relapsed/Refractory DLBCL in Partial Remission with Deauville Score of 4 or 5 after Salvage Chemotherapy
Authors: Siyuan Chen, Li Wang, Pengpeng Xu, Shu Cheng, Wei Tang, Wen Wu, Mengmeng Ji, Zhong Zheng, Zixun Yan, Lingshuang Sheng, Yige Shen, Weili Zhao
Journal: Blood (2024)
Efficacy and Safety of Momelotinib in Myelofibrosis: A Systematic Review and Meta-Analysis with a Focus on Anemia Outcomes
Authors: Mo'Men Aldalal'Ah, Jowan Al-Nusair, Nora Al-Khateeb, Mohammad Alqudah, Omar El-shatel, Fakhri M AlMalkawi, Obada Khayyat, Sarah H AlSeid, Hasan A Khasawneh, Ola Soudah, Mahmoud Abdallah
Journal: Blood (2024)